KANUMA (Alexion Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the KANUMA drug offered from Alexion Pharmaceuticals, Inc.. This Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC],Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC],Lysosomal Acid Cholesterol Esterase [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alexion Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Sebelipase alfa
SUBSTANCE NAME: SEBELIPASE ALFA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC],Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC],Lysosomal Acid Cholesterol Esterase [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2015-12-08
END MARKETING DATE: 0000-00-00


KANUMA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionKANUMA from Alexion Pharmaceuticals, Inc.
LABELER NAME: Alexion Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/mL)
START MARKETING DATE: 2015-12-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25682-007_1a7945ac-ac7a-4fd8-920f-ec3aa7ee6ff0
PRODUCT NDC: 25682-007
APPLICATION NUMBER: BLA125561

Other SEBELIPASE ALFA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alexion Pharmaceuticals, Inc.KANUMA